The topical application of 12-O-tetradecanoylphorbol-13-acetate (TPA), which induces skin inflammation in animal models [7], increases TLR4, TNF, and various inflammatory cytokines [8,9,10,11]. The gene discussed is TLR4; the disease is dermatitis.